Genesis Medtech Group Raises Significant Growth Investment in Latest Round of Series B Financing | BusinessNewsAsia.com  Business News Asia. : Genesis MedTech Group (Genesis), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital and others. The majority of shareholders from Series A followed up with additional investments. Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors.